Troels Koch

CTO at MiNA Therapeutics

Troels joined MiNA in 2021 and leads chemistry research and strategy. Troels brings over 20 years of leadership in RNA therapeutics research, drug discovery and company building. He previously led RNA therapeutics research at Roche as Chief Technology Officer and VP Research, Roche Innovation Centre Copenhagen. Prior to its acquisition by Roche, Troels held the same role at Santaris where he worked for 11 years and founded its predecessor companies Cureon and Exiqon. Troels has a PhD in Bioorganic Chemistry from the University of Copenhagen.

Timeline

  • CTO

    Current role

  • SVP, Chemistry

View in org chart